Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 07 October 2021
      From Covid-19 to the next pandemic, why innovation matters
 
 
Listen to the RPS podcast
 
Royal Pharmaceutical Society's Chief Scientist Gino Martini chats with Nathalie Moll and Sunayana Shah about lessons learnt from COVID-19, how the industry is getting prepared to tackle future health threats such as AMR, and about the exciting innovations in the R&D pipeline.


Read more →
 
 
      News
 
  07 October 2021 EFPIA calls for a Greater Harmonisation of Genetically Modified Organism (GMO) Procedures for...

Each EU Member State should enable a practical and efficient system to allow greater coordination of the GMO assessment...

Read more →
 
 
 
      Blogs
 
  05 October 2021 European cancer care can rise like a phoenix

Beating Cancer: Together we can reclaim lost momentum to deliver measurable advances

Read more →
 
 
 
      Catch up with EFPIA's recent events
 
 
 
How can we close the East-West healthcare investment gap in Europe?
Representatives from the European Commission, patients organisations and the industry discussed the reforms which would be needed for CEE countries to meet future healthcare challenges and be financially sustainable over the longer term.
 
 
Health Systems after COVID-19 - How can the industry contribute to strengthened resilience?
In the effort to making health systems more resilient to future pandemics and other shocks, both public institutions and private stakeholders have an important role to play.
 
 
 
 
      Events
 
 
11 OCT 2021
  Technical meeting on Achieving Equity and Innovation in Newborn Screening and in... Virtual event

An accompanying event of the Slovenian Presidency of the Council of the European Union 2021

Learn more →
 
 
 
12 OCT 2021
  How can we make the impossible possible for rare and paediatric disease? Virtual event

Join the conversation to outline ways forward towards lowering the remaining unmet needs.

Learn more →
 
 
 
08 NOV 2021
  Global Pharmaceutical and Biotechnology Conference Virtual event

Sustaining innovation and collaboration beyond the pandemic #FTPharma

Learn more →
 
 
 
16 NOV 2021
  Learnings from 'gene delivery' COVID vaccines relevant to ATMP Virtual event

The focus of this years ATMP Sweden conference is to extract learnings from the development and implementation of 'gene...

Learn more →
 
 
      An end to suffering from Alzheimer’s
Together we can make the impossible, possible.

Memory loss and disorientation in familiar places. Difficulty recognizing family and friends. Personality changes and paranoia. Trouble walking and performing everyday tasks. These are not just the inevitable parts of growing older. They’re the symptoms of Alzheimer’s, a disease robbing Europeans of their memories and identities on a scale that should halt policymakers in their tracks.

Read more on POLITICO.eu...


 
 
      What we are reading
Everyone must have a seat at the table when it comes to delivering Europe’s Beating Cancer... 29 September 2021  (The Parliament Magazine) Read more →
Flu Vaccination More Important Than Ever to Ensure Global Healthcare Systems Protect Most Vulnerable... 29 September 2021  (Pharma Boardroom) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe